SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-023827
Filing Date
2022-11-09
Accepted
2022-11-09 16:03:57
Documents
14
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nktx-20221109.htm   iXBRL 8-K 67607
2 EX-99.1 nktx-ex99_1.htm EX-99.1 223465
3 GRAPHIC img220989892_0.jpg GRAPHIC 6297
  Complete submission text file 0000950170-22-023827.txt   435425

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktx-20221109_pre.xml EX-101.PRE 11359
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktx-20221109.xsd EX-101.SCH 2452
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktx-20221109_lab.xml EX-101.LAB 13896
8 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20221109_htm.xml XML 4887
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39370 | Film No.: 221372476
SIC: 2834 Pharmaceutical Preparations